Advertisement
Home Tags Genetics

Tag: Genetics

Dementia Risk Up in Men With Genetic Mutation for Hemochromatosis

0

Male p.C282Y homozygotes have lower T2* measures on brain MRI in areas including the putamen, thalamus, hippocampus

Biomarker May Predict Treatment Outcome in Advanced Melanoma

0

Changes in plasma levels of ctDNA associated with survival outcomes in BRAF V600 mutation-positive unresectable or metastatic melanoma

Actionable Drug-Gene Interactions Common in U.K. Primary Care

0

Actionable drug-gene interactions identified in 19.1 to 21.1 percent of all new prescriptions for 56 drugs

Genetic Data Suggest Increases in BP May Cause A-Fib

0

Causal relationship of BP and a-fib did not change when SNPs associated with possible confounders were excluded

Positive BRCA Test Results Down From 2008 to 2018

Genes That Best Predict Breast Cancer Risk Identified

0

And estimates determined for breast cancer risk in association with pathogenic variants in known predisposition genes

Los confinamientos podrían estar manteniendo a raya a los ataques de asma de los niños

EPA, DHA Intake From Fish May Reduce Childhood Asthma Risk

0

Higher intake at age 7 years linked to lower odds of incident asthma at 11 or 14 years among FADS minor G allele carriers

B 11/5 Smoking Bans May Not Guard Against Secondhand Smoke: Study

Causal Link Suggested for Smoking, Subarachnoid Hemorrhage

0

Genetic susceptibility to smoking, assessed using polygenic risk score, is associated with increased risk for SAH

Autistic Traits ID’d in Carriers of CNVs Linked to Autism

0

54 percent of carriers of certain copy number variants have elevated levels of autistic traits

Review: Nearly One in Five With SARS-CoV-2 Has GI Manifestations

Polygenic Risk Scores May Improve IBD Risk Prediction

0

For every population in BioMe biobank, combining risk scores from distinct ancestral populations improved risk prediction for IBD

Pembrolizumab Slows MSI-H-dMMR Metastatic CRC

Triple Treatment Combo Beneficial in BRAF-Mutant CRC

0

Irinotecan, cetuximab, and vemurafenib improve progression-free survival in BRAFV600E-mutated colorectal cancer